Medical management of uveitis - current trends
- PMID: 23803479
- PMCID: PMC3744780
- DOI: 10.4103/0301-4738.114099
Medical management of uveitis - current trends
Abstract
Uveitis is a challenging disease to treat. Corticosteroids have been used in the treatment of uveitis for many years. Immunosuppressives are gaining momentum in recent years in the treatment of uveitis. In this article we present an overview of current treatment of uveitis and the major breakthroughs and advances in drugs and ocular drug delivery systems in the treatment of uveitis.
Conflict of interest statement
References
-
- Nussenblatt RB, Whitcupp SM. Fundamentals and Clinical Practice. 4th ed. Philadelphia, PA: Mosby-Elsevier; 2010. Philosophy, goals and approach to medical therapy. Uveitis; pp. 76–113.
-
- Cunningham ET, Jr, Wender JD. Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol. 2010;45:352–8. - PubMed
-
- Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513. - PubMed
-
- The loteprednol etabonate US Uveitis Study Group. Controlled Evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol. 1999;127:537–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
